Praxis Precision Medicines, Inc.
KCNT1 INHIBITORS AND METHODS OF USE

Last updated:

Abstract:

The present invention is directed to, in part, compounds and compositions useful for preventing and/or treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene (e.g., KCNT1). Methods of treating a neurological disease or disorder, a disease or condition relating to excessive neuronal excitability, and/or a gain-of-function mutation in a gene such as KCNT1 are also provided herein.

Status:
Application
Type:

Utility

Filling date:

1 May 2020

Issue date:

18 Aug 2022